Lataa...
Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
BACKGROUND: Sulindac is an FDA-approved non-steroidal anti-inflammatory drug (NSAID) that affects prostaglandin production by inhibiting cyclooxygenases (COX) 1 and 2. Sulindac has also been of interest for more than decade as a chemopreventive for adenomatous colorectal polyps and colon cancer. PRI...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686156/ https://ncbi.nlm.nih.gov/pubmed/19503837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0005804 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|